143 related articles for article (PubMed ID: 16855443)
21. FDG-PET in diagnostic work-up of pulmonary artery sarcomas.
Tueller C; Fischer Biner R; Minder S; Gugger M; Stoupis C; Krause TM; Carrel TP; Schmid RA; Vock P; Nicod LP
Eur Respir J; 2010 Feb; 35(2):444-6. PubMed ID: 20123849
[No Abstract] [Full Text] [Related]
22. Usefulness of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in a case of choriocarcinoma presenting as pulmonary embolism.
Zaheer S; Osmany S; Lai HK; Eng DN
Clin Nucl Med; 2009 Jun; 34(6):343-5. PubMed ID: 19487841
[TBL] [Abstract][Full Text] [Related]
23. EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism.
Park JS; Chung JH; Jheon S; Choi DJ; Yoon HI; Lee JH; Lee CT; Lee SW
Eur Respir J; 2011 Dec; 38(6):1480-2. PubMed ID: 22130766
[No Abstract] [Full Text] [Related]
24. Infected pacemaker causing septic lung emboli detected on FDG PET/CT.
Abikhzer G; Turpin S; Bigras JL
J Nucl Cardiol; 2010 Jun; 17(3):514-5. PubMed ID: 19876696
[No Abstract] [Full Text] [Related]
25. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
27. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
[TBL] [Abstract][Full Text] [Related]
29. Introduction to clinical positron emission tomography.
Agress H
N J Med; 2000 Oct; 97(10):25-30. PubMed ID: 11064564
[TBL] [Abstract][Full Text] [Related]
30. [The application of 18F-fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer].
Xu HF; Liu Y; Zhang JH; Zhou RS; Zhou FH; Yuan MH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):108-11. PubMed ID: 15854393
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET/CT images of patients with nonthoracic malignancies.
O JH; Yoo IeR; Kim SH; Sohn HS; Chung SK
J Nucl Med; 2007 Jan; 48(1):15-21. PubMed ID: 17204694
[TBL] [Abstract][Full Text] [Related]
32. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
33. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
Nomori H; Kosaka N; Watanabe K; Ohtsuka T; Naruke T; Kobayashi T; Uno K
Ann Thorac Surg; 2005 Dec; 80(6):2020-5. PubMed ID: 16305837
[TBL] [Abstract][Full Text] [Related]
34. False positivity of FDG-PET during hemophagocytic lymphohistiocytosis in a child with Hodgkin lymphoma in remission.
Corapcioglu F; Oncel S; Berberoğlu K; Klç SC; Aydoğan A; Doğan S
J Pediatr Hematol Oncol; 2009 Jan; 31(1):74-5. PubMed ID: 19125095
[No Abstract] [Full Text] [Related]
35. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
36. How much intravenous contrast is needed in FDG-PET/CT?
Strobel K; Thuerl CM; Hany TF
Nuklearmedizin; 2005; 44 Suppl 1():S32-7. PubMed ID: 16395976
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary tumor thrombotic microangiopathy: FDG-PET/CT findings.
Tashima Y; Abe K; Matsuo Y; Baba S; Kaneko K; Isoda T; Yabuuchi H; Sasaki M; Honda H
Clin Nucl Med; 2009 Mar; 34(3):175-7. PubMed ID: 19352285
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary hypertrophic osteoarthropathy in a patient with nonsmall cell lung cancer: Diagnosis with FDG PET/CT.
Strobel K; Schaefer NG; Husarik DB; Hany TF; Steinert H
Clin Nucl Med; 2006 Oct; 31(10):624-6. PubMed ID: 16985370
[No Abstract] [Full Text] [Related]
39. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
40. Simple pulmonary eosinophilia evaluated by means of FDG PET: the findings of 14 cases.
Kim TJ; Lee KW; Kim HY; Lee JH; Kim EA; Kim SK; Kang KW
Korean J Radiol; 2005; 6(4):208-13. PubMed ID: 16374077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
